首页> 外国专利> OBESITY POLYPEPTIDE (OB) (VARIANTS), ITS ANALOGUE (VARIANTS), AND FUSED PROTEIN (VARIANTS), NUCLEIC ACID ISOLATED MOLECULE, DNA MOLECULE, CLONING RECOMBINANT VECTOR, EXPRESSION RECOMBINANT VECTOR, PHARMACEUTICAL COMPOSITION, MONOCLONAL AND POLYCLONAL ANTIBODY

OBESITY POLYPEPTIDE (OB) (VARIANTS), ITS ANALOGUE (VARIANTS), AND FUSED PROTEIN (VARIANTS), NUCLEIC ACID ISOLATED MOLECULE, DNA MOLECULE, CLONING RECOMBINANT VECTOR, EXPRESSION RECOMBINANT VECTOR, PHARMACEUTICAL COMPOSITION, MONOCLONAL AND POLYCLONAL ANTIBODY

机译:肥胖多肽(OB)(变体),其类似物(变体)和融合蛋白(变体),核酸分离的分子,DNA分子,克隆重组矢量,表达重组矢量,药物组成和多肽,单核苷酸

摘要

FIELD: biotechnology, molecular biology, medicine.;SUBSTANCE: invention discloses amino acid sequences of human obesity polypeptide (OB) two isoforms possessing capacity for modulation of animal body mass, their signal peptide-containing precursors and analogues. Polypeptide isoforms are prepared as result of insertions, deletions and amino acid changes that retain activity typical for nonmodified forms of OB-polypeptides, and polyclonal and monoclonal antibodies interaction specifically with new agents modulating the body mass value also. Invention describes DNA sequences encoding these polypeptides and their analogues, vector structures comprising these sequences used for preparing recombinant forms of OB-polypeptides. Invention proposes using new polypeptides and their analogues as an active component in pharmaceutical compositions. Using this invention can promote to solving the problem for providing medicine, veterinary science and animal husbandry with effective agent used for decreasing the body mass value. Invention can be used in medicine for diagnosis and treatment of pathological states associated with disturbance of regulation of human body mass, and in animal husbandry and veterinary science.;EFFECT: valuable biological, medicinal and veterinary properties of polypeptide.;23 cl, 71 dwg, 12 tbl, 17 ex
机译:领域:本发明公开了人类肥胖多肽(OB)的两种具有调节动物体重能力的同工型的氨基酸序列,其包含信号肽的前体和类似物。由于插入,缺失和氨基酸变化而制得的多肽同工型,保留了非修饰形式的OB多肽通常具有的活性,并且多克隆抗体和单克隆抗体还与调节体重值的新试剂特异性相互作用。本发明描述了编码这些多肽及其类似物的DNA序列,包括用于制备OB-多肽的重组形式的这些序列的载体结构。本发明提出使用新的多肽及其类似物作为药物组合物中的活性成分。使用本发明可以促进解决为医学,兽医学和畜牧业提供用于降低体重值的有效试剂的问题。本发明可用于诊断和治疗与人体质量调节失调有关的病理状态的药物,以及用于畜牧和兽医学。效果:该多肽的有价值的生物学,医学和兽医学性质; 23 cl,71 dwg ,12 tbl,17 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号